Mercado global de tecnologia de diagnóstico molecular multiplex – Tendências do setor e previsão para 2029

Análise e dimensão do mercado de tecnologia de diagnóstico molecular multiplex

Espera-se que o mercado da tecnologia de diagnóstico molecular multiplex cresça durante o período de previsão. O diagnóstico molecular multiplex é utilizado para encontrar doenças como o vírus H1N1, clamídia e outras infeções. A procura dos utilizadores finais por diagnóstico molecular multiplex deverá aumentar como resultado da descoberta de tais doenças. Para testes analíticos únicos, os ensaios imunoenzimáticos (ELISA) são amplamente utilizados para avaliar quantitativamente a presença de proteína numa amostra.

A Data Bridge Market Research analisa que o mercado da tecnologia de diagnóstico molecular multiplex, que foi de 37,04 mil milhões de dólares em 2021, subiria para 76,00 mil milhões de dólares até 2029 e deverá passar por um CAGR de 9,40% durante o período de previsão de 2022 a 2029. Além disso aos insights de mercado, tais como o valor de mercado, a taxa de crescimento, os segmentos de mercado, a cobertura geográfica, os participantes do mercado e o cenário de mercado, o relatório de mercado com curadoria da equipa de investigação de mercado da Data Bridge inclui também análise especializada aprofundada, epidemiologia do paciente, análise de pipeline, análise de preços e estrutura regulamentar.

Âmbito e segmentação do mercado da tecnologia de diagnóstico molecular multiplex      

Definição de mercado

A multiplexagem permite a identificação de uma vasta gama de condições, em vez de realizar procedimentos individuais separados, ao realizar um método de teste de diagnóstico molecular. Permite detetar múltiplas características, doenças ou sequências genéticas de uma só vez, incluindo as associadas aos genes do cancro.

Dinâmica global do mercado de tecnologia de diagnóstico molecular multiplex

Motoristas

• Aumento dos procedimentos de testes rápidos

Globalmente, a epidemia do novo coronavírus causou enormes perdas à humanidade. São necessários procedimentos de teste rápido para combater a crescente taxa de transmissão do vírus COVID-19. À medida que os kits de teste RT-PCR se tornam o padrão de ouro da indústria, existe uma enorme procura global por eles. Este elemento pode encorajar os produtores do mercado de tecnologia de diagnóstico molecular multiplex a aumentar.

• Aumento da procura por diagnóstico molecular multiplex

Espera-se que o diagnóstico molecular multiplex tenha uma elevada procura durante o período de previsão. O aumento da estabilidade económica resulta em melhores cuidados de saúde e financiamento da investigação, o que aumenta a procura de tecnologia de diagnóstico molecular multiplex.

O mercado de diagnóstico molecular multiplex está a expandir-se à medida que as doenças gastrointestinais, respiratórias e do SNC se tornam mais comuns.

Oportunidades

• Desenvolvimentos tecnológicos

O mercado da tecnologia de diagnóstico molecular multiplex está a ganhar força significativa com os novos avanços tecnológicos. Por exemplo, a Bosch Healthcare Solutions desenvolveu um dos primeiros testes de diagnóstico molecular multiplex do mundo que consegue detetar a COVID-19 e distingui-la de mais de 8 doenças respiratórias. Este produto eliminará confusões inúteis e ajudará na diferenciação do paciente.

Restrições/Desafios

Por outro lado, os orçamentos limitados para I&D e o abrandamento económico irão obstruir a taxa de crescimento do mercado. A escassez de profissionais qualificados e a falta de infraestruturas de saúde nas economias em desenvolvimento desafiarão o mercado da tecnologia de diagnóstico molecular multiplex.

This multiplex molecular diagnosis technology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the multiplex molecular diagnosis technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Multiplex Molecular Diagnosis Technology Market

The impact of COVID-19 on multiplex molecular diagnosis technology is positive during the pandemic. US FDA has been approved many instruments in the diagnosis of COVID-19. The surge in demand for polymerase chain reaction tests, next-generation sequencing (NGS), serology-based rapid-test products, and a dramatic increase in the target patient population are all predicted to contribute to an increase in the demand for diagnostics as a result of COVID-19 in Brazil. For instance, Seegene Inc., a pioneer in multiplex PCR technology development, provided Brazil with five million Allplex 2019-nCOV assay tests in May 2020 through its subsidiary Seegene do Brasil Diagnosticos Ltda.

Recent Development

• In July 2020, For the purpose of assisting with SARS CoV-2 diagnostic testing, Roche Diagnostics India launched the Cobas 8800 instrument at the National Institute of Cholera and Enteric Diseases in Kolkata and the Cobas 6800 at the National Institute for Research in Reproductive Health in Mumbai. The Cobas 6800/8800 systems from Roche offer faster turnaround times, increased flexibility, and test results in three and a half hours.
• In January 2020, The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) granted Illumina product approval for the MiSeqDx equipment. The MiSeqDx can now be sold in Japan as a Class I medical equipment, which will have a favourable effect on the market.

Global Multiplex Molecular Diagnosis Technology Market Scope

The multiplex molecular diagnosis technology market is segmented on the basis of product type and method. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Analyzers
• Software
• Instruments
• Centrifuge
• Counting Chambers
• Incubators

 Method

• Real-time PCR
• Nested PCR with Melt Curve Analysis
• PCR with Low Density Microarray
• PCR with Liquid Phase Bead Array
• PCR with Electrochemical Detection

Multiplex Molecular Diagnosis Technology Market Regional Analysis/Insights

The multiplex molecular diagnosis technology market is analysed and market size insights and trends are provided by country, product type and method as referenced above.

The countries covered in the multiplex molecular diagnosis technology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the multiplex molecular diagnosis technology market due to the well- equipped infrastructure, patient awareness, advancement of techniques among others.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising demand for improved multiplex molecular diagnosis technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Multiplex Molecular Diagnosis Technology Market Share Analysis

The multiplex molecular diagnosis technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to multiplex molecular diagnosis technology market.

Some of the major players operating in the multiplex molecular diagnosis technology market are:

• Siemens (Germany)
• Hologic, Inc. (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Abbott (U.S.)
• BD (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• NeuroLogica Corp. (U.S.)
• Shimadzu Medical (India) pvt. Ltd. (Japan)
• GENERAL ELECTRIC (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Sysmex India Pvt. Ltd. (Japan)
• Hitachi, Ltd. (Japan)
• Canon Inc. (Japan)
• FUJIFILM Holdings Corporation (Reino Unido)

SKU-55001